Exane Asset Management - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
Exane Asset Management ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2020$718,136,000
-24.2%
39,458
-25.7%
0.51%
-17.2%
Q3 2020$947,161,000
-0.5%
53,0920.0%0.62%
-36.7%
Q2 2020$951,940,000
+18.1%
53,0920.0%0.98%
-37.6%
Q1 2020$805,937,000
-23.1%
53,0920.0%1.57%
+22.1%
Q4 2019$1,047,505,000
-2.8%
53,092
-15.2%
1.29%
+55.6%
Q3 2019$1,077,374,000
-78.3%
62,638
-77.6%
0.83%
-62.4%
Q2 2019$4,956,000,000
-43.5%
280,000
-34.9%
2.20%
-48.4%
Q1 2019$8,766,617,000
-44.2%
430,369
-53.9%
4.26%
-53.7%
Q4 2018$15,700,898,000933,4669.21%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2019
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders